Inactive Instrument
Aoxing Pharmaceutical Company, Inc. Stock Other OTC
Stocks
AOXG
US03740A1060
Professional & Business Education
OTC Markets Traded
| Market Cap | 23.62M 20.4M 18.8M 17.6M 32.98M 2.25B 33.5M 222M 86.56M 1.09B 88.66M 86.78M 3.78B | P/E Ratio 2015 |
20.1x | P/E Ratio 2016 | 23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 42.18M 36.43M 33.57M 31.43M 58.9M 4.01B 59.81M 396M 155M 1.95B 158M 155M 6.76B | EV / Sales 2015 |
5.77x | EV / Sales 2016 | 2.11x |
| Free-Float |
100% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | -20.71% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chun Fai Lo
CEO | Chief Executive Officer | - | - |
Po Chim
DFI | Director of Finance/CFO | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -20.71% | -19.80% | - | - | 1.6M | |
| -4.02% | -10.17% | +16.56% | +463.98% | 2.16B | |
| 0.00% | -4.61% | -28.87% | -59.41% | 1.89B | |
| +6.92% | +0.49% | - | - | 1.79B | |
| -3.07% | -3.83% | +105.48% | +633.70% | 1.46B | |
| +0.22% | +0.89% | -30.05% | +39.26% | 1.29B | |
| +4.24% | -0.73% | +106.56% | +95.80% | 1.17B | |
| -0.48% | -2.15% | +360.15% | +912.10% | 1.06B | |
| -0.34% | +3.11% | +57.02% | +42.63% | 988M | |
| -6.58% | +6.77% | -41.64% | -91.13% | 418M | |
| Average | -2.38% | -0.52% | +68.15% | +254.62% | 1.36B | |
| Weighted average by Cap. | +0.07% | -1.74% | +61.68% | +282.90% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 25.48M 22.01M 20.28M 18.98M 35.58M 2.42B 36.13M 239M 93.37M 1.18B 95.63M 93.59M 4.08B | 32.33M 27.92M 25.73M 24.09M 45.14M 3.07B 45.84M 304M 118M 1.5B 121M 119M 5.18B |
| Net income | 5.49M 4.75M 4.37M 4.09M 7.67M 522M 7.79M 51.64M 20.13M 254M 20.62M 20.18M 880M | 2.06M 1.78M 1.64M 1.54M 2.88M 196M 2.92M 19.37M 7.55M 95.36M 7.74M 7.57M 330M |
| Net Debt | 24.8M 21.42M 19.74M 18.48M 34.63M 2.36B 35.17M 233M 90.89M 1.15B 93.09M 91.11M 3.97B | 18.56M 16.03M 14.77M 13.83M 25.91M 1.76B 26.31M 174M 68.01M 859M 69.66M 68.17M 2.97B |
Employees
-
